{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:58Z","timestamp":1792783798923,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technology, R.O.C.","award":["MOST 100-2314-B002-027-MY3"],"award-info":[{"award-number":["MOST 100-2314-B002-027-MY3"]}]},{"name":"Ministry of Science and Technology, R.O.C.","award":["MOST 102-2314-B002-132-MY3"],"award-info":[{"award-number":["MOST 102-2314-B002-132-MY3"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bpobgyn.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T12:05:15Z","timestamp":1460117115000},"page":"119-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Hepatic manifestations of women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"37","author":[{"given":"Mei-Jou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Nerng","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2016.03.003_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bpg.2013.06.014","article-title":"Liver abnormalities and endocrine diseases","volume":"27","author":"Burra","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0973-6883(12)60102-9","article-title":"Epidemiology and natural History of non-alcoholic fatty liver disease","volume":"2","author":"Mishra","year":"2012","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1440-1746.2007.05001.x","article-title":"Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines","volume":"22","author":"Chitturi","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background","volume":"38","author":"Kojima","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib5","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1073\/pnas.0608537103","article-title":"Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men","volume":"103","author":"Petersen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","article-title":"Prevalence of and risk factors for hepatic steatosis in Northern Italy","volume":"132","author":"Bellentani","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib8","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2004-1024","article-title":"Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease","volume":"90","author":"Angelico","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib9","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hepres.2005.09.007","article-title":"The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease","volume":"33","author":"Hashimoto","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib13","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1053\/j.gastro.2008.09.018","article-title":"Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease","volume":"135","author":"Goessling","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","article-title":"Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study","volume":"328","author":"Kim","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib15","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1053\/j.gastro.2007.08.077","article-title":"Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999\u20132004","volume":"133","author":"Fraser","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.fertnstert.2013.08.015","article-title":"Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile","volume":"100","author":"Michaliszyn","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","article-title":"Women with polycystic ovary syndrome gain regular menstrual cycles when ageing","volume":"15","author":"Elting","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib19","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A\u00a020-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib22","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2012-1690","article-title":"Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study","volume":"97","author":"Morgan","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib23","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tjog.2012.09.014","article-title":"Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome","volume":"51","author":"Chang","year":"2012","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib25","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/humrep\/del175","article-title":"Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS","volume":"21","author":"Chen","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS)","volume":"27","author":"Amsterdam EA-SrPCWG","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib29","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome","volume":"91","author":"Setji","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00365521.2010.539251","article-title":"Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)","volume":"46","author":"Hossain","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib33","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?","author":"Targher","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib34","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2014.05.015","article-title":"Effect of the combination of metformin hydrochloride and melatonin on oxidative stress before and during pregnancy, and biochemical and histopathological analysis of the livers of rats after treatment for polycystic ovary syndrome","volume":"280","author":"Lemos","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib36","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib37","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib38","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.atherosclerosis.2015.02.011","article-title":"The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"239","author":"Al Rifai","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib41","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/jhep.2002.32483","article-title":"Nonalcoholic fatty liver disease: an agenda for clinical research","volume":"35","author":"Younossi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"Vassilatou","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4158\/EP.11.5.319","article-title":"Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings","volume":"11","author":"Brown","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib45","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib48","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib49","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A\u00a0position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-137-1-200207020-00012","article-title":"Alanine aminotransferase levels: what's normal?","volume":"137","author":"Kaplan","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib51","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib52","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","article-title":"Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome","volume":"95","author":"Chen","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/jc.2009-1834","article-title":"Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome","volume":"95","author":"Tan","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib54","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib55","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ijo.2013.161","article-title":"Slowing down of adult body mass index trend increases in England: a latent class analysis of cross-sectional surveys (1992-2010)","volume":"38","author":"Sperrin","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib56","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib57","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","article-title":"Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis","volume":"13","author":"Lazo","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/qjmed\/92.2.73","article-title":"Fatty liver\u2013an additional and treatable feature of the insulin resistance syndrome","volume":"92","author":"Knobler","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/eje.1.01821","article-title":"Plasma adiponectin is decreased in nonalcoholic fatty liver disease","volume":"152","author":"Pagano","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib60","doi-asserted-by":"crossref","first-page":"18070","DOI":"10.3748\/wjg.v20.i48.18070","article-title":"Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Stojsavljevic","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib61","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib62","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijcard.2015.08.107","article-title":"Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders","volume":"201","author":"Lim","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib63","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/jc.2013-2674","article-title":"Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study","volume":"98","author":"Puurunen","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jc.2008-1750","article-title":"The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study","volume":"94","author":"Sathyapalan","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib65","first-page":"CD008623","article-title":"Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"12","author":"Eslami","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","article-title":"Is PCOS an inflammatory process?","volume":"97","author":"Duleba","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib67","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.fertnstert.2009.06.009","article-title":"The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome","volume":"92","author":"Chen","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib68","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tjog.2014.11.025","article-title":"Iron stores and obesity are negatively associated with ovarian volume and anti-Mullerian hormone levels in women with polycystic ovary syndrome","volume":"54","author":"Yang","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib69","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/diacare.28.8.2042","article-title":"Body iron stores are increased in overweight and obese women with polycystic ovary syndrome","volume":"28","author":"Escobar-Morreale","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib70","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/dc14-1239","article-title":"Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: guidelines for referral in NAFLD","volume":"38","author":"Bazick","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib71","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/humrep\/des209","article-title":"Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome","volume":"27","author":"Chen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib72","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/humrep\/dep459","article-title":"Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome","volume":"25","author":"Chen","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib73","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib74","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2337\/dc07-0642","article-title":"Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses","volume":"30","author":"Luque-Ramirez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib75","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/phar.1623","article-title":"Prevalence, pathophysiology, and management of androgen deficiency in men with metabolic syndrome, type 2 diabetes mellitus, or both","volume":"35","author":"Taylor","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib76","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1210\/jc.2006-1895","article-title":"Endogenous sex hormones and glucose tolerance status in postmenopausal women","volume":"92","author":"Golden","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib77","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib78","first-page":"4346","article-title":"Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis","volume":"62","author":"Yeh","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib79","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.05.046","article-title":"Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma","volume":"135","author":"Ma","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib80","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1530\/ERC-13-0283","article-title":"Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis","volume":"21","author":"Ma","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/joe.0.1750113","article-title":"Sex hormone-binding globulin is synthesized in target cells","volume":"175","author":"Kahn","year":"2002","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib82","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF03401306","article-title":"Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2013","journal-title":"Hormones"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib83","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijc.28342","article-title":"Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?","volume":"134","author":"Lukanova","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/humrep\/deq308","article-title":"High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome","volume":"26","author":"Chen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib85","doi-asserted-by":"crossref","first-page":"18319","DOI":"10.1038\/srep18319","article-title":"The effect of androgens on ovarian follicle maturation: dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARgamma-dependent PTEN expression","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib86","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/humrep\/dev010","article-title":"Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations","volume":"30","author":"Huang","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib87","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.22063","article-title":"Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease","volume":"47","author":"Charlton","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib88","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1478-3231.2011.02637.x","article-title":"Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients","volume":"32","author":"Koehler","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib89","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/humrep\/dei004","article-title":"Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women","volume":"20","author":"Ibanez","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib90","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2012.06.018","article-title":"Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females","volume":"98","author":"Bruni","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib91","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1665-2681(19)31595-9","article-title":"Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature","volume":"10","author":"Brahm","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib92","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199305273282108","article-title":"Hormonal contraception","volume":"328","author":"Baird","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib93","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00535-012-0715-8","article-title":"Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III","volume":"48","author":"Liu","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib94","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-89-5-643","article-title":"Spironolactone therapy for hirsutism in a hyperandrogenic woman","volume":"89","author":"Ober","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib95","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1470320311402110","article-title":"Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2011","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib96","doi-asserted-by":"crossref","first-page":"E1415","DOI":"10.1152\/ajpendo.00419.2013","article-title":"Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet","volume":"305","author":"Wada","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib97","doi-asserted-by":"crossref","first-page":"E1645","DOI":"10.1210\/jc.2011-1093","article-title":"Metformin and\/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome","volume":"96","author":"Aubuchon","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib98","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/09513590.2010.488769","article-title":"Letrozole induces hepatotoxicity without causing oxidative stress: the protective effect of melatonin","volume":"27","author":"Aydin","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib99","first-page":"1299","article-title":"Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients","volume":"7","author":"Murata","year":"2000","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bpobgyn.2016.03.003_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2214\/ajr.180.1.1800129","article-title":"Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy","volume":"180","author":"Nishino","year":"2003","journal-title":"AJR Am J Roentgenol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T06:40:05Z","timestamp":1567752005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693416300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":100,"alternative-id":["S1521693416300013"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.03.003","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic manifestations of women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}